Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Net Cash Flow (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Net Cash Flow for 4 consecutive years, with $41.8 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Net Cash Flow fell 47.92% year-over-year to $41.8 million, compared with a TTM value of -$63.4 million through Dec 2023, down 166.27%, and an annual FY2024 reading of $81.6 million, up 228.6% over the prior year.
  • Net Cash Flow was $41.8 million for Q4 2023 at Terns Pharmaceuticals, up from -$43.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $80.2 million in Q4 2022 and bottomed at -$103.3 million in Q2 2023.
  • Average Net Cash Flow over 4 years is $4.2 million, with a median of -$1.7 million recorded in 2020.
  • Peak annual rise in Net Cash Flow hit 5181.82% in 2021, while the deepest fall reached 493.0% in 2021.
  • Year by year, Net Cash Flow stood at $61.2 million in 2020, then plummeted by 127.9% to -$17.1 million in 2021, then skyrocketed by 569.8% to $80.2 million in 2022, then crashed by 47.92% to $41.8 million in 2023.
  • Business Quant data shows Net Cash Flow for TERN at $41.8 million in Q4 2023, -$43.0 million in Q3 2023, and -$103.3 million in Q2 2023.